Quantcast

Latest Nephrogenic Systemic Fibrosis Stories

2013-11-26 23:00:43

Guebert announces largest exhibit presence ever at Radiology Society of North America Annual Meeting Princeton, NJ (PRWEB) November 26, 2013 Guerbet announced today that it will have the company’s largest exhibit presence ever at the Radiology Society of North America (RSNA)’s 99th Assembly and Annual Meeting Dec. 1-6 in Chicago. Guerbet will be exhibiting at Booth #2535 South Building, Hall A. This will mark the first RSNA for Guerbet since the U.S. Food and Drug Administration...

2013-09-05 23:00:38

Guerbet announces first US adult injection of Dotarem (gadoterate meglumine) Princeton, NJ (PRWEB) September 05, 2013 Guerbet announced today that Winthrop-University Hospital in Mineola, NY recently performed the first US adult injection of Dotarem® (gadoterate meglumine), the only macrocyclic and ionic gadolinium-based contrast agent (GBCA) approved by the US Food and Drug Administration. The procedure was performed in an adult with borderline renal function. It follows the first...

2012-10-09 04:00:48

The national class action lawyers at Glen Lerner Injury Attorneys announced that they are now reviewing potential gadolinium contrast claims for people with impaired kidneys who underwent a magnetic resonance image (MRI) scan that used a gadolinium contrast agent. These individuals may be at risk for developing Nephrogenic Systemic Fibrosis (NSF). Any individuals that suffer from kidney disease who have been exposed to a Gadolinium MRI contrast agent are encouraged to call 1 (800) GET-GLEN...

2011-05-18 06:54:05

(Ivanhoe Newswire) -- A simple blood test may help prevent a serious complication associated with a contrast agent commonly used in MRI exams. Within the past five years, use of gadolinium-based contrast agents (GBCA) has been linked to the development of nephrogenic systemic fibrosis (NSF), a rare disorder mainly affecting patients with severe kidney disease. But since 2008, restrictive GBCA administration guidelines implemented by Massachusetts General Hospital have proven effective in...

2011-05-03 13:36:01

A recent study shows how one medical center implemented strict protocols for administering gadolinium-based contrast agents (GBCAs) before imaging and eliminated new cases for nephrogenic system fibrosis (NSF). Implementing this protocol is particularly important for patients with diminished kidney function says Dr. Ozden Narin, presenting author for this study. "In the past, we had some patients who developed NSF after they were given a gadolinium-based agent before imaging. We implemented...

2011-03-15 09:45:00

SILVER SPRING, Md., March 15, 2011 /PRNewswire-USNewswire/ --The U.S. Food and Drug Administration approved Gadavist (gadobutrol), a gadolinium-based contrast agent, for use in patients undergoing magnetic resonance imaging (MRI) of the central nervous system. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) Gadavist was approved by the FDA on March 14. It provides contrast-enhanced imaging of the central nervous system, helping to detect and visualize lesions that disrupt the...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related